These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12680739)

  • 1. Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man.
    Passie T; Karst M; Borsutzky M; Wiese B; Emrich HM; Schneider U
    J Psychopharmacol; 2003 Mar; 17(1):51-6. PubMed ID: 12680739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of subanesthetic doses of ketamine on sensorimotor information processing in healthy subjects.
    Micallef J; Guillermain Y; Tardieu S; Hasbroucq T; Possamaï C; Jouve E; Blin O
    Clin Neuropharmacol; 2002; 25(2):101-6. PubMed ID: 11981237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of different subanesthetic doses of (S)-ketamine on neuropsychology, psychopathology, and state of consciousness in man.
    Passie T; Karst M; Wiese B; Emrich HM; Schneider U
    Neuropsychobiology; 2005; 51(4):226-33. PubMed ID: 15897673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
    Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
    Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of nabilone and cannabidiol on binocular depth inversion in Man.
    Leweke FM; Schneider U; Radwan M; Schmidt E; Emrich HM
    Pharmacol Biochem Behav; 2000 May; 66(1):175-81. PubMed ID: 10837858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of a subanaesthetic dose of ketamine on emotional and behavioral state in healthy subjects].
    Micallef J; Tardieu S; Gentile S; Fakra E; Jouve E; Sambuc R; Blin O
    Neurophysiol Clin; 2003 Jun; 33(3):138-47. PubMed ID: 12909392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological modulation of the effects induced by ketamine at subanesthetic doses].
    Mechri A; Micallef J; Blin O; Saoud M; Daléry J; Gaha L
    Therapie; 2001; 56(5):617-22. PubMed ID: 11806303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers.
    Morgan CJ; Mofeez A; Brandner B; Bromley L; Curran HV
    Neuropsychopharmacology; 2004 Jan; 29(1):208-18. PubMed ID: 14603267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine.
    Sinner B; Graf BM
    Handb Exp Pharmacol; 2008; (182):313-33. PubMed ID: 18175098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychedelic effects of subanesthetic doses of ketamine].
    Zou L; Tian SY; Quan X; Ye TH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):68-72. PubMed ID: 19317064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance on a probabilistic inference task in healthy subjects receiving ketamine compared with patients with schizophrenia.
    Evans S; Almahdi B; Sultan P; Sohanpal I; Brandner B; Collier T; Shergill SS; Cregg R; Averbeck BB
    J Psychopharmacol; 2012 Sep; 26(9):1211-7. PubMed ID: 22389244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine associated psychedelic effects and dependence.
    Lim DK
    Singapore Med J; 2003 Jan; 44(1):31-4. PubMed ID: 12762561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers.
    De Simoni S; Schwarz AJ; O'Daly OG; Marquand AF; Brittain C; Gonzales C; Stephenson S; Williams SC; Mehta MA
    Neuroimage; 2013 Jan; 64():75-90. PubMed ID: 23009959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of unpleasant dreams after sub-anaesthetic ketamine.
    Blagrove M; Morgan CJ; Curran HV; Bromley L; Brandner B
    Psychopharmacology (Berl); 2009 Mar; 203(1):109-20. PubMed ID: 18949459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine dependence.
    Pal HR; Berry N; Kumar R; Ray R
    Anaesth Intensive Care; 2002 Jun; 30(3):382-4. PubMed ID: 12075653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia.
    Lahti AC; Koffel B; LaPorte D; Tamminga CA
    Neuropsychopharmacology; 1995 Aug; 13(1):9-19. PubMed ID: 8526975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.
    Lofwall MR; Griffiths RR; Mintzer MZ
    Exp Clin Psychopharmacol; 2006 Nov; 14(4):439-49. PubMed ID: 17115871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of ketamine dependence].
    Błachut M; Sołowiów K; Janus A; Ruman J; Cekus A; Matysiakiewicz J; Hese RT
    Psychiatr Pol; 2009; 43(5):593-9. PubMed ID: 20214100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.